'Spermbots' Could Help Women Trying to Conceive (includes video)
By Phys.org,
Phys.org
| 01. 13. 2016
Sperm that don't swim well rank high among the main causes of infertility. To give these cells a boost, women trying to conceive can turn to artificial insemination or other assisted reproduction techniques, but success can be elusive. In an attempt to improve these odds, scientists have developed motorized "spermbots" that can deliver poor swimmers—that are otherwise healthy—to an egg. Their report appears in ACS' journal Nano Letters.
Artificial insemination is a relatively inexpensive and simple technique that involves introducing sperm to a woman's uterus with a medical instrument. Overall, the success rate is on average under 30 percent, according to the Human Fertilisation & Embryology Authority of the United Kingdom. In vitro fertilization can be more effective, but it's a complicated and expensive process. It requires removing eggs from a woman's ovaries with a needle, fertilizing them outside the body and then transferring the embryos to her uterus or a surrogate's a few days later.
Each step comes with a risk for failure. Mariana Medina-Sánchez, Lukas Schwarz, Oliver G. Schmidt and colleagues from the Institute for Integrative...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Eric Schmidt, TIME | 04.16.2024
Imagine a world where everything from plastics to concrete is produced from biomass. Personalized cell and gene therapies prevent pandemics and treat previously incurable genetic diseases. Meat is lab-grown; enhanced nutrient grains are climate-resistant. This is what the future could...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Jorge Barrera and Rachel Houlihan, CBC | 04.09.2024
A Canadian DNA laboratory knowingly delivered prenatal paternity test results that routinely identified the wrong biological fathers — ruling out the real dads — and left a trail of shattered lives around the globe, a CBC News investigation has found...